Laura Riolobos

1.2k total citations · 1 hit paper
9 papers, 862 citations indexed

About

Laura Riolobos is a scholar working on Molecular Biology, Infectious Diseases and Oncology. According to data from OpenAlex, Laura Riolobos has authored 9 papers receiving a total of 862 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 4 papers in Infectious Diseases and 4 papers in Oncology. Recurrent topics in Laura Riolobos's work include Virus-based gene therapy research (4 papers), Parvovirus B19 Infection Studies (4 papers) and Nuclear Structure and Function (3 papers). Laura Riolobos is often cited by papers focused on Virus-based gene therapy research (4 papers), Parvovirus B19 Infection Studies (4 papers) and Nuclear Structure and Function (3 papers). Laura Riolobos collaborates with scholars based in Spain, United States and France. Laura Riolobos's co-authors include Roli K. Hirata, David W. Russell, Cameron J. Turtle, Germán G. Gornalusse, José M. Almendral, Vanda S. Lopes, Gabriel Manske, Dennis Clegg, Laïla‐Aïcha Hanafi and Donna Prunkard and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Biotechnology and Journal of Molecular Biology.

In The Last Decade

Laura Riolobos

9 papers receiving 841 citations

Hit Papers

HLA-E-expressing pluripotent stem cells escape allogeneic... 2017 2026 2020 2023 2017 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Laura Riolobos Spain 8 503 305 227 163 158 9 862
Chu-Chih Shih United States 10 524 1.0× 135 0.4× 209 0.9× 104 0.6× 144 0.9× 13 945
David Onion United Kingdom 14 474 0.9× 182 0.6× 333 1.5× 48 0.3× 113 0.7× 43 847
Lauren E. Mays United States 9 761 1.5× 116 0.4× 441 1.9× 63 0.4× 172 1.1× 10 1.0k
Kilian Guse Finland 22 717 1.4× 570 1.9× 781 3.4× 92 0.6× 127 0.8× 32 1.3k
Hideyo Ugai Japan 18 895 1.8× 216 0.7× 473 2.1× 79 0.5× 97 0.6× 47 1.1k
Jamie L. Shirley United States 7 562 1.1× 192 0.6× 448 2.0× 39 0.2× 101 0.6× 13 824
Douglas C. Wu United States 16 598 1.2× 74 0.2× 99 0.4× 210 1.3× 264 1.7× 21 1.1k
Maria Teresa Sáenz-Robles United States 14 750 1.5× 420 1.4× 184 0.8× 59 0.4× 125 0.8× 19 1.2k
Wolf Bertling Germany 16 467 0.9× 113 0.4× 118 0.5× 91 0.6× 216 1.4× 36 1.1k

Countries citing papers authored by Laura Riolobos

Since Specialization
Citations

This map shows the geographic impact of Laura Riolobos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Riolobos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Riolobos more than expected).

Fields of papers citing papers by Laura Riolobos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura Riolobos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Riolobos. The network helps show where Laura Riolobos may publish in the future.

Co-authorship network of co-authors of Laura Riolobos

This figure shows the co-authorship network connecting the top 25 collaborators of Laura Riolobos. A scholar is included among the top collaborators of Laura Riolobos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura Riolobos. Laura Riolobos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Schroeder, Brett, Bonnie LaFleur, Rachel Gittelman, et al.. (2021). CD4+ T cell and M2 macrophage infiltration predict dedifferentiated liposarcoma patient outcomes. Journal for ImmunoTherapy of Cancer. 9(8). e002812–e002812. 25 indexed citations
2.
Riolobos, Laura, Ekram Gad, Piper M. Treuting, et al.. (2019). The Effect of Mouse Strain, Sex, and Carcinogen Dose on Toxicity and the Development of Lung Dysplasia and Squamous Cell Carcinomas in Mice. Cancer Prevention Research. 12(8). 507–516. 9 indexed citations
3.
4.
Gornalusse, Germán G., Roli K. Hirata, Sarah E. Funk, et al.. (2017). HLA-E-expressing pluripotent stem cells escape allogeneic responses and lysis by NK cells. Nature Biotechnology. 35(8). 765–772. 446 indexed citations breakdown →
5.
Hernando, Eva, et al.. (2015). The Mammalian Cell Cycle Regulates Parvovirus Nuclear Capsid Assembly. PLoS Pathogens. 11(6). e1004920–e1004920. 17 indexed citations
6.
Riolobos, Laura, Roli K. Hirata, Cameron J. Turtle, et al.. (2013). HLA Engineering of Human Pluripotent Stem Cells. Molecular Therapy. 21(6). 1232–1241. 195 indexed citations
7.
Riolobos, Laura, Noelia Valle, Eva Hernando, et al.. (2009). Viral Oncolysis That Targets Raf-1 Signaling Control of Nuclear Transport. Journal of Virology. 84(4). 2090–2099. 31 indexed citations
8.
Riolobos, Laura, Juan Reguera, Mauricio G. Mateu, & José M. Almendral. (2006). Nuclear Transport of Trimeric Assembly Intermediates Exerts a Morphogenetic Control on the Icosahedral Parvovirus Capsid. Journal of Molecular Biology. 357(3). 1026–1038. 55 indexed citations
9.
Reguera, Juan, Aura Carreira, Laura Riolobos, José M. Almendral, & Mauricio G. Mateu. (2004). Role of interfacial amino acid residues in assembly, stability, and conformation of a spherical virus capsid. Proceedings of the National Academy of Sciences. 101(9). 2724–2729. 79 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026